Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4‐methylenedioxymethamphetamine): Assessment using quantitative autoradiography

Synapse - Tập 8 Số 4 - Trang 249-260 - 1991
George Battaglia1,2, John Sharkey3,2, Michael J. Kuhar3,2, Errol B. De Souza3,2
1Department of Pharmacology, Loyola University Chicago, Stritch School of Medicine, 2160 South First Avenue, Maywood, IL 60153
2Neuroscience Branch, Addiction Research Center, National Institute on Drug Abuse, Baltimore, Maryland 21224
3Department of Pharmacology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois 60153

Tóm tắt

AbstractThe Widely abused “designer” durg MDMA (3,4‐methylenedioxymethamphetamine) has been shown to caused marked and long‐lasting changes in brain serotonergic systems. The present study uses quantitative in vitro autoradiography of 3H‐paroxetine labeled 5‐HT uptake sites to assess the time‐dependent effects of MDMA on 5‐HT neurons in specific neuroanatomic loci. Following treatment with MDMA (20 mg/kg, b.i.d. for 4 days), marked decreases in 5‐HT uptake sites were observed in a number of brain regions known to receive projections of ‐5HT neurons. These regions included cerebral cortex, caudate nucleus, hippocampus, nucleus accumbens, olfactory tubercle, superior and inferior colliculi, geniculate nuclei, and most thalamic nuclei. In contrast, other areas such as the septal nuclei and some thalamic nuclei which also receive 5‐HT projections were not substantially affected by this drug. In most regions, decreases in 5‐HT uptake sites occurred within 24 hours of the last dose of MDMA and persisted at the 2 week time point. Some regions such as dorsal striatum exhibited a time‐dependent reduction with greater reductions occurring at 2 weeks rather than immediately following the MDMA treatment regimen. The density of 5‐HT uptake sites in other regions such as endopiriform nucleus and substantia nigra at the 2 week versus 18 hour time point indicated some degree of region‐specific recovery. Regions which demonstrated no significant reduction in 5‐HT uptake sites included the dorsal and median raphe nuclei, ventral tegmental area, central grey, interpeduncluar nucleus, locus coerulus, pontine reticular formation and cerebellum. Likewise, region containing 5‐HT axons of passage (e.g., indusium griseum and lateral hypothalamus) appeared to be insensitive to the neurotoxic effects of MDMA on 5‐HT neurons. Furthermore, the neurotoxic effects of MDMA showed specificity in that the catecholamine neurons labeled by 3H‐mazindol were unaffected by the treatment regimen. These data indicate that the preferential degeneration of serotonergic neurons by MDMA is mediated primarily at 5‐HT terminal regions, whereas regions containg 5‐HT perikarya and axons of passage remain relatively unaffected. In addition, the observed time‐dependent reductions and recovery of 5‐HT uptake sites which were detected within 2 weeks of the treatment regimen in certain brain regions suggest region‐specific differences in recovery of 5‐HT systems from MDMA‐induced lesion.

Từ khóa


Tài liệu tham khảo

Adler J. Abramson B. Katz S. andHager M.(1985)Getting high on “Ecstasy”. Newsweek April 15:96.

Appel N. M., 1989, Fenfluramine selctively and differentially decreases the density of serotonergic nerve terminals in rat brain: Evidence from immunocytochemical studies, J. Pharmacol. Exp. Ther., 249, 928

10.1002/syn.890060105

10.1126/science.2893452

10.1007/978-94-009-1912-9_85

Battaglia G., 1987, 3,4 methylenedioxymethamphetamine and 3,4 methylenedioxyamphetamine destroy serotonin terminals in rat brain: Quantification of neurodegeneration by measurement of 3H‐paroxetine labeled serotonin uptake sites, J. Pharmacol. Exp., Ther., 242, 911

10.1016/0091-3057(88)90155-4

Commins D. L., 1987, Biochemical and histological evidence that methylenedioxymethamphetamine (MDMA) is toxic to neurons in rat brain, J. Pharmacol. Exp. Ther., 241, 338

D'Amato R. J., 1987, Selective labelling of serotonin uptake sites in rat brain by 3H‐citalopram constrasted to labelling of multiple sites by 3H‐imipramine, J. Pharmacol. Exp. Ther., 242, 364

10.1002/syn.890010513

10.1016/0006-8993(89)90562-3

10.1111/j.1749-6632.1978.tb31521.x

Gertz K. R.(1986)The agony of ecstasy. Science Digest February:27.

Insel T. R., 1989, 3,4 Methylenedioxymethamphetamine (“Ecstasy”) selectively destroys brain serotonin terminals in Rhesus monkeys, J. Pharmacol. Exp. Ther., 249, 713

Javitch J. A., 1985, Differential visualization of dopamine and norepinephrine uptake sites in rat brain using 3H‐mazindol autoradiography, J. Neurosci., 5, 1513, 10.1523/JNEUROSCI.05-06-01513.1985

10.1002/syn.890010204

10.1016/0006-8993(89)90122-4

Kovachich G. B., 1990, Effects of repeated administration of antidepressants on serotonin (5‐HT) uptake sites measured using 3H‐cyanoimipramine autoradiography, Soc. Neurosci. Abstr., 16, 1040

10.1016/0014-4886(88)90075-1

10.1097/00004714-198712001-00002

10.1111/j.1749-6632.1978.tb31531.x

O'Hearn E., 1988, Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause ablation of serotonergic axons terminals in forebrain: Immunocytochemical evidence for neurotoxicity, J. Neurosci., 8, 2788, 10.1523/JNEUROSCI.08-08-02788.1988

Paxinos G., 1982, The Rat in Stereotaxic Coordinates

10.1126/science.4023719

Ricaurte G. A., 1988, (±) 3,4‐methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates, JAMA, 260, 51, 10.1001/jama.1988.03410010059035

10.1111/j.1749-6632.1978.tb31525.x

10.1016/0006-2952(87)90566-1

10.1016/0306-4522(81)90146-9

10.1016/0028-3908(87)90117-1

10.1002/cne.901860408

10.1111/j.1749-6632.1978.tb31534.x

Zaczek R., 1989, Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: Pharmacokinetic, dose response, regional specificity and time course data, J. Pharmacol. Exp. Ther., 253, 104

Thông tin
Thông tin xuất bản

Synapse

Tập 8 Số 4

249-260

Thông tin tác giả